Clinical Trials Directory

Trials / Unknown

UnknownNCT02516371

Lymphocytes Subpopulation in Cancer Patients

Lymphocytes Subpopulation and Its Relevance With Tumor Grade and Prognosis in Cancer Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
DERSHENG SUN · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to exam the subpopulation of lymphocytes and evaluate the clinico-pathologic correlations.

Detailed description

The host's inflammatory response in the tumor microenvironment could effect cancer progression and prognosis. As components of systemic inflammatory response, lymphocytes, neutrophils, and platelets are being recognised to have an important role in carcinogenesis and tumor progression. To date, a number of peripheral blood-derived inflammation-based scores such as the neutrophil-lymphocyte ratio (NLR), platelet- lymphocyte ratio (PLR) and so on have been proposed as prognostic markers in numerous types of cancers. But, very little is known of their impact in subpopulation of lymphocytes. The investigators try to evaluate the activity of lymphocytes in peripheral blood and find out the relationship among clinical prognosis.

Conditions

Interventions

TypeNameDescription
OTHERlymphocyteTo evaluate the subpopulation of lymphocytes in cancer patients

Timeline

Start date
2015-08-01
Primary completion
2016-06-01
Completion
2018-12-01
First posted
2015-08-05
Last updated
2015-08-26

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02516371. Inclusion in this directory is not an endorsement.